<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>35(1)</volume><submitter>Kamaz B</submitter><funding>NHLBI NIH HHS</funding><journal>Leukemia</journal><pagination>279-281</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7586362</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>COVID-19 and myeloproliferative neoplasms: some considerations.</pubmed_title><pmcid>PMC7586362</pmcid><funding_grant_id>R01 HL131835</funding_grant_id><pubmed_authors>Kamaz B</pubmed_authors><pubmed_authors>Mullally A</pubmed_authors></additional><is_claimable>false</is_claimable><name>COVID-19 and myeloproliferative neoplasms: some considerations.</name><description/><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-04-26T20:10:23.434Z</modification><creation>2025-04-06T16:20:43.347Z</creation></dates><accession>S-EPMC7586362</accession><cross_references><pubmed>33106624</pubmed><doi>10.1038/s41375-020-01070-8</doi></cross_references></HashMap>